The presence of peptides in the G1 region produced by degradation of aggrecan in the synovial fluid of patients with early RA suggests that aggrecan may be involved in the induction and maintenance of autoimmune responses in RA (77). This evidence concerns the gene ACAN and rheumatoid arthritis.